Onset of efficacy and tolerability following the initiation dosing of long-acting paliperidone palmitate: post-hoc analyses of a randomized, double-blind clinical trial

BACKGROUND: Paliperidone palmitate is a long-acting injectable atypical antipsychotic for the acute and maintenance treatment of adults with schizophrenia. The recommended initiation dosing regimen is 234 mg on Day 1 and 156 mg on Day 8 via intramuscular (deltoid) injection; followed by 39 to 234 mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Bossie, Cynthia A, Sliwa, Jennifer K, Ma, Yi-Wen, Fu, Dong-Jing, Alphs, Larry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115849/
https://www.ncbi.nlm.nih.gov/pubmed/21569242
http://dx.doi.org/10.1186/1471-244X-11-79

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115849/
https://www.ncbi.nlm.nih.gov/pubmed/21569242
http://dx.doi.org/10.1186/1471-244X-11-79

Ejemplares similares